Characterization of the Human p53 Gene Promoter

LITERATURE CITED

• Aviv, H., and P. Leder. 1972. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc. Natl. Acad. Sci. USA 69:1408–1412.
   PubMed Web of Science ®Google Scholar
• Banks, L. M., G. Matlashewski, and L. V. Crawford. 1986. Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur. J. Biochem. 159:529–534.
   PubMedGoogle Scholar
• Bendori, R., D. Resnitzky, and A. Kimchi. 1987. Changes in p53 mRNA expression during terminal differentiation of murine erythroleukemia cells. Virology 161:607–611.
   PubMedGoogle Scholar
• Berk, A. J., and P. A. Sharp. 1977. Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease digested hybrids. Cell 12:721–732.
   PubMed Web of Science ®Google Scholar
• Bienz-Tadmor, B., R. Zakut-Houri, S. Libresco, D. Givol, and M. Oren. 1985. The 5′ region of the p53 gene: evolutionary conservation and evidence for a negative regulatory element. EMBO J. 4:3209–3213.
   PubMed Web of Science ®Google Scholar
• Bolivar, F., R. L. Rodriguez, P. J. Greene, M. C. Betlach, H. L. Heynecker, H. W. Boyer, J. H. Crosa, and S. Falkow. 1977. Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene 2:95–113.
   PubMed Web of Science ®Google Scholar
• Bradford, M. M.. 1976. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254.
   PubMed Web of Science ®Google Scholar
• Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299.
   PubMed Web of Science ®Google Scholar
• Chow, V., Y. Ben-David, A. Bernstein, S. Benchimol, and M. Mowat. 1987. Multistage Friend erythroleukemia: independent origin of tumor clones with normal and rearranged p53 cellular oncogenes. J. Virol. 61:2777–2781.
   PubMedGoogle Scholar
• Crawford, L. V., D. C. Pim, and R. D. Bulbrook. 1982. Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int. J. Cancer 30:403–408.
   PubMed Web of Science ®Google Scholar
• Crawford, L. V., D. C. Pim, and P. Lamb. 1984. The cellular protein p53 in human tumors. Mol. Cell. Biol. 2:261–272.
   Google Scholar
• DeLeo, A. B., G. Jay, E. Appela, G. C. Dubois, L. W. Law, and L. Old. 1979. Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc. Natl. Acad. Sci. USA 76:2420–2424.
   PubMed Web of Science ®Google Scholar
• Dippold, W. G., G. Jay, A. B. DeLeo, G. Khoury, and L. J. Old. 1981. p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells. Proc. Natl. Acad. Sci. USA 78:1695–1699.
   PubMed Web of Science ®Google Scholar
• Dony, C., M. Kessel, and P. Gruss. 1985. Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9. Nature (London) 317:636–639.
   PubMedGoogle Scholar
• Filmus, J., S. Benchimol, and R. N. Buick. 1987. Comparative analysis of the involvement of p53, c-myc and c-fos in epidermal growth factor-mediated signal transduction. Exp. Cell. Res. 169:554–559.
   PubMedGoogle Scholar
• Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyl-transferase in mammalian cells. Mol. Cell. Biol. 2:1044–1051.
   PubMed Web of Science ®Google Scholar
• Graham, F. L., and A. J. Van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus DNA. Virology 52:456–467.
   PubMed Web of Science ®Google Scholar
• Heard, J. M., P. Herbomel, M. O. Ott, A. Mottura-Rollier, M. Weiss, and M. Yaniv. 1987. Determinants of rat albumin promoter tissue specificity analyzed by an improved transient expression system. Mol. Cell. Biol. 7:2425–2434.
   PubMedGoogle Scholar
• Herbomel, P., B. Bourachot, and M. Yaniv. 1984. Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell 39:653–662.
   PubMed Web of Science ®Google Scholar
• Jay, G., A. B. DeLeo, E. Appella, G. C. Dubois, L. W. Law, G. Khoury, and L. H. Old. 1979. A common transformation-related protein in murine sarcomas and leukemias. Cold Spring Harbor Symp. Quant. Biol. 44:659–664.
   Google Scholar
• Khochbin, S., E. Principaud, A. Chabanas, and J. J. Lawrence. 1988. Early events in murine erythroleukaemia cells induced to differentiate: accumulation and gene expression of the transformation associated cellular protein p53. J. Mol. Biol. 200:55–64.
   PubMedGoogle Scholar
• Koeffler, H. P., C. Miller, M. A. Nicolson, J. Ranyard, and R. A. Bosselman. 1986. Increased expression of p53 protein in human leukemia cells. Proc. Natl. Acad. Sci. USA 83:4035–4039.
   PubMed Web of Science ®Google Scholar
• Kozak, M.. 1988. Leader length and secondary structure modulate mRNA function under conditions of stress. Mol. Cell. Biol. 8:2737–2744.
   PubMed Web of Science ®Google Scholar
• Krieg, P. A., and D. A. Melton. 1984. Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs. Nucleic Acids Res. 12:7057–7069.
   PubMed Web of Science ®Google Scholar
• Lamb, P., and L. V. Crawford. 1986. Characterization of the human p53 gene. Mol. Cell. Biol. 6:1379–1385.
   PubMed Web of Science ®Google Scholar
• Linzer, D. I. H., and A. J. Levine. 1979. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17:43–52.
   PubMed Web of Science ®Google Scholar
• Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Masuda, H., C. Miller, H. P. Koeffler, H. Battifora, and M. J. Cline. 1987. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc. Natl. Acad. Sci. USA 84:7716–7719.
   PubMed Web of Science ®Google Scholar
• Matlashewski, G., L. M. Banks, D. C. Pim, and L. V. Crawford. 1986. Analysis of human p53 proteins and mRNA levels in normal and transformed cells. Eur. J. Biochem. 154:665–672.
   PubMedGoogle Scholar
• Matlashewski, G. J., P. Lamb, D. C. Pim, J. Peacock, L. V. Crawford, and S. Benchimol. 1984. Isolation and characterisation of a human p53 cDNA clone: expression of the human p53 gene. EMBO J. 3:3257–3262.
   PubMed Web of Science ®Google Scholar
• Matlashewski, G. J., S. P. Tuck, D. C. Pim, P. Lamb, J. Schneider, and L. V. Crawford. 1987. Primary structure polymorphism at amino acid residue 72 of human p53. Mol. Cell. Biol. 7:961–963.
   PubMed Web of Science ®Google Scholar
• Maxam, A. M., and W. Gilbert. 1977. A new method for sequencing DNA. Proc. Natl. Acad. Sci. USA 74:560–564.
   PubMed Web of Science ®Google Scholar
• McGeady, M. L., T. G. Wood, J. V. Maizel, and G. F. Vande Woude. 1986. Sequences upstream from the mouse c-mos oncogene may function as a transcription termination signal. DNA 5:289–298.
   PubMedGoogle Scholar
• Milner, J., and F. McCormick. 1980. Lymphocyte stimulation: concanavalin A induces the expression of a 53K protein. Cell Biol. Int. Rep. 4:663–667.
   PubMedGoogle Scholar
• Mowat, M., A. Cheng, N. Kimura, A. Bernstein, and S. Benchimol. 1985. Rearrangements of the cellular p53 gene in erythro-leukaemic cells transformed by Friend virus. Nature (London) 314:633–636.
   PubMed Web of Science ®Google Scholar
• Oren, M., W. Maltzman, and A. J. Levine. 1981. Posttranslational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol. Cell. Biol. 1:101–110.
   PubMed Web of Science ®Google Scholar
• Oren, M., N. C. Reich, and A. J. Levine. 1982. Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny. Mol. Cell. Biol. 2:443–449.
   PubMed Web of Science ®Google Scholar
• Prost, E., and D. D. Moore. 1986. CAT vectors for analysis of eukaryotic promoters and enhancers. Gene 45:107–111.
   PubMed Web of Science ®Google Scholar
• Reich, N. C., and A. J. Levine. 1984. Growth regulation of a cellular tumour antigen, p53, in non-transformed cells. Nature (London) 308:199–201.
   PubMed Web of Science ®Google Scholar
• Reich, N. C., M. Oren, and A. J. Levine. 1983. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Mol. Cell. Biol. 3:2143–2150.
   PubMed Web of Science ®Google Scholar
• Reisman, D., M. Greenberg, and V. Rotter. 1988. Human p53 oncogene contains one promoter upstream of exon 1 and a second, stronger promoter within intron 1. Proc. Natl. Acad. Sci. USA 85:5146–5158.
   PubMedGoogle Scholar
• Rogel, A., M. Popliker, C. G. Webb, and M. Oren. 1985. p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol. Cell. Biol. 5:2851–2855.
   PubMed Web of Science ®Google Scholar
• Rotter, V.. 1983. p53, a transformation-related cellular-encoded protein, can be used as a biochemical marker for the detection of primary mouse tumor cells. Proc. Natl. Acad. Sci. USA 80:2613–2617.
   PubMed Web of Science ®Google Scholar
• Rotter, V., O. N. Witte, R. Coffman, and D. Baltimore. 1980. Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, p50. J. Virol. 36:547–555.
   PubMed Web of Science ®Google Scholar
• Ruscetti, S. K., and E. M. Scolnick. 1983. Expression of a transformation-related protein, p53, in the malignant stage of Friend virus-induced diseases. J. Virol. 46:1022–1026.
   PubMedGoogle Scholar
• Schirm, S., J. Jiricny, and W. Schaffner. 1987. The SV40 enhancer can be dissected into multiple segments each with a different cell type specificity. Genes Dev. 1:65–74.
   PubMed Web of Science ®Google Scholar
• Sleigh, M. J.. 1986. A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eukaryotic cells. Anal. Biochem. 156:251–256.
   PubMed Web of Science ®Google Scholar
• Smith, L. J., E. A. McCulloch, and S. Benchimol. 1986. Expression of the p53 oncogene in acute myeloblastic leukaemia. J. Exp. Med. 164:751–761.
   PubMed Web of Science ®Google Scholar
• Todaro, G. J., H. Green, and M. R. Swift. 1966. Susceptibility of human diploid fibroblast strains to transformation by SV40 virus. Science 153:1252–1254.
   PubMed Web of Science ®Google Scholar
• Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350–4354.
   PubMed Web of Science ®Google Scholar
• Wigler, M., A. Pellicer, S. Silverstein, and R. Axel. 1978. Biochemical transfer of single copy eukaryotic genes using total cellular DNA as donor. Cell 14:725–731.
   PubMed Web of Science ®Google Scholar
• Yewdell, J. W., J. V. Gannon, and D. P. Lane. 1986. Monoclonal antibody analysis of p53 expression in normal and transformed cells. J. Virol. 59:444–452.
   PubMed Web of Science ®Google Scholar
• Zakut-Houri, R., D. Givol, B. Bienz, A. Rogel, and M. Oren. 1984. p. 393–401. In G. F. Vande Woude, A. J. Levine, W. C. Topp, and J. D. Watson (ed.), Cancer cells, vol. 2: oncogenes and viral genes. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar